Mass Tort Advertising Campaign
Hernia mesh litigation centers on polypropylene implants manufactured by Bard, Covidien, Ethicon, and Atrium — devices that have been linked to mesh failure, chronic pain, infection, and hernia recurrence in patients who underwent repair procedures. Because these implants were placed in enormous numbers of patients over many years, the pool of individuals who experienced serious complications and may not yet be connected to a plaintiff firm remains substantial.
For plaintiff firms currently in the MDL or evaluating entry, paid social acquisition on Meta platforms is one of the most direct ways to reach affected individuals before they find a competitor. Intake is open, the injury profile is specific enough to qualify leads efficiently, and the revision-surgery subset represents a high-signal claimant audience that responds well to targeted creative.
Hernia mesh cases are consolidated in active MDL proceedings, reflecting the volume and seriousness of claims against manufacturers including Bard, Covidien, Ethicon, and Atrium. Plaintiffs allege that polypropylene mesh products failed after implantation — causing mesh migration, chronic pain, infection, and hernia recurrence that in many cases required additional surgical intervention to address. The multi-manufacturer landscape means claimants may have received products from any of several defendants, and a well-structured intake process can identify the responsible device from surgical records.
Because hernia repair is one of the most commonly performed surgical procedures, the potential claimant population spans a wide demographic range. Many affected individuals have already undergone revision surgery and are living with ongoing complications but have not yet pursued legal representation — making them an actively reachable audience through paid social when the creative speaks directly to their experience.
On Facebook and Instagram, hernia mesh creative performs best when it leads with the specific failure experience rather than generic legal messaging. Ads that reference the physical reality of mesh complications — unexpected pain returning after surgery, a second operation to remove or repair the implant, an infection that wouldn't resolve — cut through the noise because they reflect what affected individuals actually lived through. This is not a tort where broad personal-injury creative converts well; the audience self-identifies around a very specific surgical experience, and the copy needs to meet them there. Manufacturer callouts (Bard, Covidien, Ethicon, Atrium) can be layered into ad sets to improve relevance and signal to claimants who remember their device brand.
Audience targeting combines interest and behavioral signals around surgical recovery, chronic pain management, and health condition communities, with lookalike modeling built from intake data as volume grows. Because the revision-surgery claimant is the priority, intake forms and landing pages should qualify on that criterion early in the flow — reducing time spent on borderline leads and improving the economics of the campaign for the firm. MTAA structures these campaigns with dedicated creative tracks for the revision-surgery audience and a separate, softer track for chronic-pain claimants who may still be building their medical record.
Mass Tort Ad Agency runs Hernia Mesh campaigns on the same transparent model as every tort: actual Meta ad spend at cost plus a flat 15% management fee, a one-time $1,000 setup fee per tort, and $100 per signed retainer for CloudIntake qualification. No per-case markups, no lead resale, and the firm owns its ad account, pixel, creative, and claimant data.
We build, run, and qualify Hernia Mesh claimant-acquisition campaigns end to end. Book a call and we'll walk you through the creative, audience, and intake plan.
Book a strategy call